These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 39185938)

  • 21. Choline Chloride-Based DES as Solvents/Catalysts/Chemical Donors in Pharmaceutical Synthesis.
    Amoroso R; Hollmann F; Maccallini C
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684867
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solubility of hesperidin drug in aqueous biodegradable acidic choline chloride-based deep eutectic solvents.
    Shekaari H; Zafarani-Moattar MT; Mokhtarpour M; Faraji S
    Sci Rep; 2023 Jul; 13(1):11276. PubMed ID: 37438381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experimental and Theoretical Insights into the Intermolecular Interactions in Saturated Systems of Dapsone in Conventional and Deep Eutectic Solvents.
    Cysewski P; Jeliński T; Przybyłek M
    Molecules; 2024 Apr; 29(8):. PubMed ID: 38675562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Solidification of deep eutectic solvent containing fimasartan through wet impregnation and exploration of flow attributes by modified SeDeM-SLA expert system.
    Dangre P; Avhad P; Gurumukhi V; Katolkar U; Chalikwar S
    Eur J Pharm Biopharm; 2024 Aug; 201():114381. PubMed ID: 38917948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overview of drug product development.
    Narayan P
    Curr Protoc Pharmacol; 2011 Dec; Chapter 7():Unit 7.3.1-29. PubMed ID: 22147349
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cyclodextrin-based supramolecular deep eutectic solvent (CycloDES): A vehicle for the delivery of poorly soluble drugs.
    Balenzano G; Racaniello GF; Arduino I; Lopedota AA; Lopalco A; Laquintana V; Denora N
    Int J Pharm; 2023 Nov; 647():123553. PubMed ID: 37884215
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmaceutical applications of therapeutic deep eutectic systems (THEDES) in maximising drug delivery.
    Javed S; Mangla B; Sultan MH; Almoshari Y; Sivadasan D; Alqahtani SS; Madkhali OA; Ahsan W
    Heliyon; 2024 May; 10(9):e29783. PubMed ID: 38694051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deep Eutectic Solvents as Active Pharmaceutical Ingredient Delivery Systems in the Treatment of Metabolic Related Diseases.
    Huang C; Chen X; Wei C; Wang H; Gao H
    Front Pharmacol; 2021; 12():794939. PubMed ID: 35002726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deep Eutectic Solvents: An Eco-friendly Design for Drug Engineering.
    Oyoun F; Toncheva A; Henríquez LC; Grougnet R; Laoutid F; Mignet N; Alhareth K; Corvis Y
    ChemSusChem; 2023 Oct; 16(20):e202300669. PubMed ID: 37463123
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solubility of pharmaceutical ingredients in triglycerides.
    Brinkmann J; Huxoll F; Luebbert C; Sadowski G
    Eur J Pharm Biopharm; 2019 Dec; 145():113-120. PubMed ID: 31682903
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design of controlled release systems for THEDES-Therapeutic deep eutectic solvents, using supercritical fluid technology.
    Aroso IM; Craveiro R; Rocha Â; Dionísio M; Barreiros S; Reis RL; Paiva A; Duarte AR
    Int J Pharm; 2015 Aug; 492(1-2):73-9. PubMed ID: 26142248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Innovative Extraction Techniques Using Deep Eutectic Solvents and Analytical Methods for the Isolation and Characterization of Natural Bioactive Compounds from Plant Material.
    Ivanović M; Islamčević Razboršek M; Kolar M
    Plants (Basel); 2020 Oct; 9(11):. PubMed ID: 33114332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmaceutical Applications of Ionic Liquids: A Personal Account.
    Md Moshikur R; Goto M
    Chem Rec; 2023 Aug; 23(8):e202300026. PubMed ID: 37042429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ionic liquids: green and tailor-made solvents in drug delivery.
    Huang W; Wu X; Qi J; Zhu Q; Wu W; Lu Y; Chen Z
    Drug Discov Today; 2020 May; 25(5):901-908. PubMed ID: 31593645
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental and Machine-Learning-Assisted Design of Pharmaceutically Acceptable Deep Eutectic Solvents for the Solubility Improvement of Non-Selective COX Inhibitors Ibuprofen and Ketoprofen.
    Cysewski P; Jeliński T; Przybyłek M; Mai A; Kułak J
    Molecules; 2024 May; 29(10):. PubMed ID: 38792157
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug carrier systems for solubility enhancement of BCS class II drugs: a critical review.
    Kumar S; Bhargava D; Thakkar A; Arora S
    Crit Rev Ther Drug Carrier Syst; 2013; 30(3):217-56. PubMed ID: 23614647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deep eutectic solvent self-assembled reverse nanomicelles for transdermal delivery of sparingly soluble drugs.
    Li B; Jiao S; Guo S; Xiao T; Zeng Y; Hu Y; Li X; Xiong S; Xu Y
    J Nanobiotechnology; 2024 May; 22(1):272. PubMed ID: 38773580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Comprehensive Review on Imperative Role of Ionic Liquids in Pharmaceutical Sciences.
    Uniyal P; Das S; Panwar S; Kukreti N; Nainwal P; Bhatia R
    Curr Drug Deliv; 2024; 21(9):1197-1210. PubMed ID: 37815183
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deep Eutectic Solvents for Efficient Drug Solvation: Optimizing Composition and Ratio for Solubility of β-Cyclodextrin.
    Shumilin I; Tanbuz A; Harries D
    Pharmaceutics; 2023 May; 15(5):. PubMed ID: 37242704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral lipid-based formulations.
    Hauss DJ
    Adv Drug Deliv Rev; 2007 Jul; 59(7):667-76. PubMed ID: 17618704
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.